Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alimena

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|May 1, 1990
Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, G Alimena, et al.
Acta Haematologica|November 1, 2008
Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromesR Latagliata, E N Oliva, P Volpicelli, et al.
Cancer Research|August 15, 1993
Southern blot analysis of ALL-1 rearrangements at chromosome 11q23 in acute leukemiaF Lo Coco, F Mandelli, M Breccia, et al.
Haematologica|August 24, 1999
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid LeukemiaG Meloni, D Russo, M Baccarani, et al.
Leukemia & Lymphoma|January 1, 1993
Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical resultsG Alimena, G Meloni, M R de Cuia, et al.
Leukemia|April 1, 1996
Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferonG Alimena, M Lazzarino, E Morra, et al.
Science (New York, N.Y.)|May 19, 1989
The myeloperoxidase gene in acute promyelocytic leukemiaE Donti, M Montanucci, L Longo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
Annals of Hematology|July 1, 1992
Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcomeE Montefusco, G Alimena, F Lo Coco, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|May 1, 1990
Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, G Alimena, et al.
Acta Haematologica|November 1, 2008
Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromesR Latagliata, E N Oliva, P Volpicelli, et al.
Cancer Research|August 15, 1993
Southern blot analysis of ALL-1 rearrangements at chromosome 11q23 in acute leukemiaF Lo Coco, F Mandelli, M Breccia, et al.
Haematologica|August 24, 1999
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid LeukemiaG Meloni, D Russo, M Baccarani, et al.
Leukemia & Lymphoma|January 1, 1993
Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical resultsG Alimena, G Meloni, M R de Cuia, et al.
Leukemia|April 1, 1996
Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferonG Alimena, M Lazzarino, E Morra, et al.
Science (New York, N.Y.)|May 19, 1989
The myeloperoxidase gene in acute promyelocytic leukemiaE Donti, M Montanucci, L Longo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
Annals of Hematology|July 1, 1992
Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcomeE Montefusco, G Alimena, F Lo Coco, et al.
Pageof 14